Cell Therapy & Gene Editing Services
Accelevir offers specialized molecular and immune analytics for cell therapies and gene editing programs — from vector copy number and integration site analysis to on/off-target editing assessment — enabling precise characterization, safety validation, and accelerated regulatory submission.
Learn MorePrecision Molecular Analytical Services
Accelevir provides ultra-sensitive, custom-tailored molecular analytics — from targeted qPCR/dPCR to next-generation sequencing — delivering the depth, accuracy, and regulatory alignment needed to accelerate complex therapeutic programs.
Learn MoreCustom Flow & Functional Immunology Assays
Accelevir develops bespoke flow cytometry and functional immunology assays — from deep immune phenotyping to cytokine profiling and cell-mediated cytotoxicity — delivering high-resolution insights to advance therapeutic efficacy and safety.
Learn MoreIntegrated Virology-Immunology Workflows
Pioneering the field of immunovirology, Accelevir integrates advanced virology and immunology analytics into unified workflows — enabling simultaneous viral load, vector, and immune response measurements from the same sample to accelerate translational decision-making.
Learn More
Who We Are
We are led by science, high integrity and social responsibility.
Accelevir is a Maryland‑based biotechnology company developing and enabling innovative assays for ultra‑rare analytes. We are driven by a strong scientific ethos with continual advancement of our operational standards. We advance disruptive technologies to market for enabling cure programs.
